Piper Sandler Maintains Overweight on Illumina, Raises Price Target to $305

Piper Sandler analyst David Westenberg has maintained an Overweight rating on Illumina (NASDAQ: ILMN) and increased the price target from $225 to $305. This adjustment reflects a positive outlook on the company's performance.